Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cynthia Gay
University of North Carolina
Study Chair - Hyman Scott
Bridge HIV
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Groote Schuur Hiv Crs
Cape Town, Western Cape, South Africa
- Emavundleni Crs
Klipfontein, Western Cape, South Africa
- Caprisa Ethekwini Crs
Durban, South Africa
- Soweto Hptn Crs
Johannesburg, South Africa
- Ward 21 Crs
Johannesburg, South Africa
- Klerksdorp Crs
Klerksdorp, South Africa
- Isipingo Crs
KwaZulu, South Africa
- Soshanguve
Soshanguve, South Africa
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Aug 2024
- Primary completion
- 14 Jan 2025
- Completion
- 14 Jan 2025
- Last update posted
- 5 Jul 2024
- Registered enrollment
- 77
- Registry id
- NCT05959707
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.